Julie Yates
- The Study to Understand Mortality and Morbidity in COPD (SUMMIT) study protocolBy Jørgen Vestbo, Julie Anderson, Robert D. Brook, Peter M.A. Calverley, Bartolome R. Celli, Courtney Crim, Brett Haumann, Fernando J. Martinez, Julie Yates and David E. NewbyJørgen VestboJulie AndersonRobert D. BrookPeter M.A. CalverleyBartolome R. CelliCourtney CrimBrett HaumannFernando J. MartinezJulie Yates
- The minimal clinically important difference (MCID) for the six minute walk (6MW) test in COPD in relation to deathBy Michael Polkey, Martijn Spruit, Lisa Edwards, Michael Watkins, Vincent Pinto-Plata, Jørgen Vestbo, Peter Calverley, Ruth Tal-Singer, Alvar Agusti, Per Bakke, Harvey Coxson, David Lomas, William MacNee, Stephen Rennard, Edwin Silverman, Bruce Miller, Courtney Crim, Julie Yates, Emiel Wouters and Bartholeme CelliMichael Polkey1Consultant Physician, Royal Brompton Hospital, London, United KingdomMartijn Spruit2Program Development Centre, CIRO+, a Centre of Expertise for Chronic Organ Failure, Horn, NetherlandsLisa Edwards3GSK, GlaxoSmithKline, Research Triangle Park,, NC, United StatesMichael Watkins3GSK, GlaxoSmithKline, Research Triangle Park,, NC, United StatesVincent Pinto-Plata4Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United StatesJørgen Vestbo5Respiratory Medicine, University of Manchester, United KingdomPeter Calverley6Department of Respiratory Medicine, School of Clinical Science, University of Liverpool, United KingdomRuth Tal-Singer7Galaxy Initiative, GlaxoSmithKline, King of Prussia, PA, United StatesAlvar Agusti8Institut del Tòrax, Hospital Clínic, IDIBAPS, CIBER Enfermedades Respiratorias and Fundación Caubet-Cimera, Barcelona, SpainPer Bakke9Institute of Medicine, University of Bergen, NorwayHarvey Coxson10Department of Radiology, Vancouver General Hospital, University of British Columbia, Vancouver, BC, CanadaDavid Lomas11Department of Medicine, Cambridge Institute for Medical Research, University of Cambridge, United KingdomWilliam MacNee12ELEGI Colt Research Labs, University of Edinburgh/MRC Centre for Inflammation Research, The Queen's Medical Research Institute, Edinburgh, United KingdomStephen Rennard13Division of Pulmonary, Critical Care, Allergy and Sleep Medicine, University of Nebraska Medical Center, Omaha, NE, United StatesEdwin Silverman14Channing Laboratory, Brigham & Women's Hospital, Boston, MA, United StatesBruce Miller7Galaxy Initiative, GlaxoSmithKline, King of Prussia, PA, United StatesCourtney Crim3GSK, GlaxoSmithKline, Research Triangle Park,, NC, United StatesJulie Yates3GSK, GlaxoSmithKline, Research Triangle Park,, NC, United StatesEmiel Wouters2Program Development Centre, CIRO+, a Centre of Expertise for Chronic Organ Failure, Horn, NetherlandsBartholeme Celli4Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States
- The relationship between persistent systemic inflammation and symptoms of depression among patients with COPD in the ECLIPSE cohortBy Daisy Janssen, Alvar Agusti, Hana Müllerova, Julie Yates, Ruth Tal-Singer, Stephen Rennard, Jorgen Vestbo and Emiel WoutersDaisy Janssen1Program Development Centre, CIRO+, Center of Expertise for Chronic Organ Failure, Horn, NetherlandsAlvar Agusti2Thorax Institute, IDIBAPS, University of Barcelona, Barcelona, SpainHana Müllerova3Respiratory and Inflammation Medicines Development Center and Worldwide Epidemiology, GlaxoSmithKline, Uxbridge, United KingdomJulie Yates3Respiratory and Inflammation Medicines Development Center and Worldwide Epidemiology, GlaxoSmithKline, Uxbridge, United Kingdom4Research Triangle Park, GlaxoSmithKline, NC, United StatesRuth Tal-Singer5Respiratory Therapy Area Unit, GlaxoSmithKline, Pennsylvania, United StatesStephen Rennard6Pulmonary and Critical Care Medicine Section, University of Nebraska Medical Centre, Nebraska, United StatesJorgen Vestbo7Department of Cardiology and Respiratory Medicine, Hvidovre Hospital and University of Copenhagen, Hvidovre, DenmarkEmiel Wouters1Program Development Centre, CIRO+, Center of Expertise for Chronic Organ Failure, Horn, Netherlands8Respiratory Medicine, Maastricht UMC+, Maastricht, Netherlands
- Objective moderate-to-vigorous physical activity in 1064 patients with COPD after stratification for gender, FEV1 and BMIBy Rafael Mesquita, Fabio Pitta, David Donaire-Gonzalez, Brenda M. Deering, Mehul Patel, Katy E. Mitchell, Jennifer Alison, Arnoldus J.R. van Gestel, Stefanie Zogg, Judith Garcia-Aymerich, Kylie Hill, Elisabeth Romme, Samantha Kon, Paul Albert, Benjamin Waschki, Dinesh Shrikrishna, Sally J. Singh, Nicholas S. Hopkinson, David Miedinger, Christine Jenkins, Michael I. Polkey, Sue C. Jenkins, William D.-C. Man, Christian F. Clarenbach, Nidia A. Hernandes, David R. Hillman, Karina C. Furlanetto, Zoe McKeough, Sally Watts, Li Whye Cindy Ng, Dina Brooks, Peter R. Eastwood, Thaís Sant'Anna, Kenneth Meijer, Selina Dürr, Malcolm Kohler, Vanessa S. Probst, Ruth M. Tal-Singer, Jörg Daniel Leuppi, Peter M.A. Calverley, Frank W. Smeenk, Julie Yates, Richard W. Costello, Roger Goldstein, Helgo Magnussen, Emiel F.M. Wouters, Richard ZuWallack, Henrik Watz and Martijn A. SpruitRafael Mesquita1Program Development Centre, Center of Expertise for Chronic Organ Failure (CIRO+), Horn, Netherlands2Laboratório De Pesquisa Em Fisioterapia Pulmonar (LFIP), Departamento De Fisioterapia, Universidade Estadual De Londrina (UEL), Londrina, BrazilFabio Pitta2Laboratório De Pesquisa Em Fisioterapia Pulmonar (LFIP), Departamento De Fisioterapia, Universidade Estadual De Londrina (UEL), Londrina, BrazilDavid Donaire-Gonzalez3Center for Research in Environmental Epidemiology, (CREAL), Barcelona, SpainBrenda M. Deering4Department of Respiratory Medicine, Beaumont Hospital, Dublin, IrelandMehul Patel5NIHR Respiratory Biomedical Research Unit, Royal Brompton & Harefield NHS Foundation Trust and Imperial College, London, United KingdomKaty E. Mitchell6NIHR CLAHRC-LNR Pulmonary Rehabilitation Research Group, University Hospitals, Leicester, United KingdomJennifer Alison7Physiotherapy Department, Royal Prince Alfred Hospital, Sydn, NSW, AustraliaArnoldus J.R. van Gestel8Pulmonary Division, University Hospital, Zurich, SwitzerlandStefanie Zogg9Internal Medicine, University Hospital, Basel, SwitzerlandJudith Garcia-Aymerich3Center for Research in Environmental Epidemiology, (CREAL), Barcelona, SpainKylie Hill10Respiratory Medicine, West Park Healthcare Centre, Toronto, Canada11School of Physiotherapy and Curtin Health Innovation Research Institute, Curtin University, Perth, WA, AustraliaElisabeth Romme12Department of Respiratory Medicine, Catharina Hospital, Eindhoven, NetherlandsSamantha Kon5NIHR Respiratory Biomedical Research Unit, Royal Brompton & Harefield NHS Foundation Trust and Imperial College, London, United KingdomPaul Albert13School of Ageing and Chronic Disease, University Hospital Aintree, Liverpool, United KingdomBenjamin Waschki14Pulmonary Research Institute at Hospital Grosshansdorf, Member of the German Centre for Lung Research, Grosshansdorf, GermanyDinesh Shrikrishna5NIHR Respiratory Biomedical Research Unit, Royal Brompton & Harefield NHS Foundation Trust and Imperial College, London, United KingdomSally J. Singh6NIHR CLAHRC-LNR Pulmonary Rehabilitation Research Group, University Hospitals, Leicester, United KingdomNicholas S. Hopkinson5NIHR Respiratory Biomedical Research Unit, Royal Brompton & Harefield NHS Foundation Trust and Imperial College, London, United KingdomDavid Miedinger9Internal Medicine, University Hospital, Basel, SwitzerlandChristine Jenkins15Woolcock Institute of Medical Research, The University of Sydney, Sydney, Camperdown, AustraliaMichael I. Polkey5NIHR Respiratory Biomedical Research Unit, Royal Brompton & Harefield NHS Foundation Trust and Imperial College, London, United KingdomSue C. Jenkins11School of Physiotherapy and Curtin Health Innovation Research Institute, Curtin University, Perth, WA, AustraliaWilliam D.-C. Man5NIHR Respiratory Biomedical Research Unit, Royal Brompton & Harefield NHS Foundation Trust and Imperial College, London, United KingdomChristian F. Clarenbach8Pulmonary Division, University Hospital, Zurich, SwitzerlandNidia A. Hernandes2Laboratório De Pesquisa Em Fisioterapia Pulmonar (LFIP), Departamento De Fisioterapia, Universidade Estadual De Londrina (UEL), Londrina, BrazilDavid R. Hillman16Department of Pulmonary Physiology, Sir Charles Gairdner Hospital, Perth, WA, AustraliaKarina C. Furlanetto2Laboratório De Pesquisa Em Fisioterapia Pulmonar (LFIP), Departamento De Fisioterapia, Universidade Estadual De Londrina (UEL), Londrina, BrazilZoe McKeough17Clinical and Rehabilitation Sciences, The University of Sydney, Sydne, NSW, AustraliaSally Watts17Clinical and Rehabilitation Sciences, The University of Sydney, Sydne, NSW, AustraliaLi Whye Cindy Ng11School of Physiotherapy and Curtin Health Innovation Research Institute, Curtin University, Perth, WA, AustraliaDina Brooks10Respiratory Medicine, West Park Healthcare Centre, Toronto, CanadaPeter R. Eastwood16Department of Pulmonary Physiology, Sir Charles Gairdner Hospital, Perth, WA, AustraliaThaís Sant'Anna2Laboratório De Pesquisa Em Fisioterapia Pulmonar (LFIP), Departamento De Fisioterapia, Universidade Estadual De Londrina (UEL), Londrina, BrazilKenneth Meijer18Department of Human Movement Science, Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, NetherlandsSelina Dürr9Internal Medicine, University Hospital, Basel, SwitzerlandMalcolm Kohler8Pulmonary Division, University Hospital, Zurich, SwitzerlandVanessa S. Probst2Laboratório De Pesquisa Em Fisioterapia Pulmonar (LFIP), Departamento De Fisioterapia, Universidade Estadual De Londrina (UEL), Londrina, BrazilRuth M. Tal-Singer19Respiratory CEDD Discovery Medicine, GlaxoSmithKline, King of Prussia, PA, United StatesJörg Daniel Leuppi9Internal Medicine, University Hospital, Basel, SwitzerlandPeter M.A. Calverley13School of Ageing and Chronic Disease, University Hospital Aintree, Liverpool, United KingdomFrank W. Smeenk12Department of Respiratory Medicine, Catharina Hospital, Eindhoven, NetherlandsJulie Yates20GlaxoSmithKline Research and Development, Research Triangle Park, NC, United StatesRichard W. Costello4Department of Respiratory Medicine, Beaumont Hospital, Dublin, IrelandRoger Goldstein10Respiratory Medicine, West Park Healthcare Centre, Toronto, CanadaHelgo Magnussen14Pulmonary Research Institute at Hospital Grosshansdorf, Member of the German Centre for Lung Research, Grosshansdorf, GermanyEmiel F.M. Wouters1Program Development Centre, Center of Expertise for Chronic Organ Failure (CIRO+), Horn, Netherlands21Department of Respiratory Medicine, Maastricht University Medical Centre (MUMC+), Maastricht, NetherlandsRichard ZuWallack22Department of Pulmonary and Critical Care, Saint Francis Hospital and Medical Center, Hartford, CT, United StatesHenrik Watz14Pulmonary Research Institute at Hospital Grosshansdorf, Member of the German Centre for Lung Research, Grosshansdorf, GermanyMartijn A. Spruit1Program Development Centre, Center of Expertise for Chronic Organ Failure (CIRO+), Horn, Netherlands
- The study to understand mortality and morbidity in COPD (SUMMIT) study protocolBy Jørgen Vestbo, Julie Anderson, Robert D Brook, Peter MA Calverley, Bartolome R Celli, Courtney Crim, Brett Haumann, Fernando Martinez, Julie Yates and David E NewbyArticle | Published in 2012 in European Respiratory JournalJørgen Vestbo*Dept of Respiratory Medicine J, Odense University Hospital and University of Southern Denmark, Odense, Denmark#Respiratory Research Group, Manchester Academic Health Sciences Centre, South Manchester University Hospital NHS Foundation Trust, Manchester, UKJulie Anderson¶Research & Development, GlaxoSmithKline, Stockley Park, Middlesex, UKRobert D Brook+University of Michigan Health System, Ann Arbor, Michigan, USAPeter MA Calverley§University of Liverpool, Dept of Medicine, Clinical Sciences Centre, University Hospital Aintree, Liverpool, UKBartolome R CellifPulmonary and Critical Care Division, Brigham and Females 's Hospital, Harvard Medical School, Boston, Massachusetts, USACourtney Crim**Research & Development, GlaxoSmithKline, Research Triangle Park, North Carolina, USABrett Haumann¶Research & Development, GlaxoSmithKline, Stockley Park, Middlesex, UKFernando Martinez##Division of Pulmonary and Critical Care Medicine, University of Michigan Health System, Ann Arbor, Michigan, USAJulie Yates**Research & Development, GlaxoSmithKline, Research Triangle Park, North Carolina, USADavid E Newby¶¶Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, UK
- One-year change in health status and outcomes in chronic obstructive pulmonary diseaseBy Sarah Wilke, Paul Jones, Hana Müllerova, Nicholas Locantore, Jorgen Vestbo, Ruth Tal-Singer, Frits Franssen, Alvar Agusti, Per Bakke, Peter Calverley, Harvey Coxson, Courtney Crim, Lisa Edwards, David Lomas, William MacNee, Stephan Rennard, Julie Yates, Emiel Wouters and Martijn SpruitSarah Wilke1Department of Research & Education, CIRO+, Centre of Expertise for Chronic Organ Failure, Horn, NetherlandsPaul Jones2Division of Clinical Science, St. George’s University of London, London, United KingdomHana Müllerova3Respiratory Epidemiology, GlaxoSmithKline, Uxbridge, United KingdomNicholas Locantore4GlaxoSmithKline, Research Triangle Park, North Carolina,Jorgen Vestbo5Department of Respiratory Medicine, Odense University Hospital, Clinical Institute, University of Southern Denmark, Odense, Denmark6Respiratory Research Group, Manchester Academic Health Sciences Centre, University Hospital South Manchester NHS Foundation, Manchester, United KingdomRuth Tal-Singer7GlaxoSmithKline, GlaxoSmithKline Research and Development, King of Prussia,Frits Franssen1Department of Research & Education, CIRO+, Centre of Expertise for Chronic Organ Failure, Horn, NetherlandsAlvar Agusti8Thorax Institute, Hospital Clinic, IDIBAPS, Universitat de Barcelona and CIBER Enfermedades Respiratorias (CIBERES), Barcelona, SpainPer Bakke9Department of Thoracic Medicine, Institute of Clinical Science, University of Bergen, Haukeland University Hospital, Bergen, NorwayPeter Calverley10Division of Infection and Immunity Clinical Sciences Centre, University Hospital Aintree, Liverpool, United KingdomHarvey Coxson11Department of Radiology, Vancouver General Hospital, University of British Columbia, Vancover, CanadaCourtney Crim4GlaxoSmithKline, Research Triangle Park, North Carolina,Lisa Edwards4GlaxoSmithKline, Research Triangle Park, North Carolina,David Lomas12University of Cambridge, Cambridge Institute for Medical Research, Department of Medicine, Cambridge, United KingdomWilliam MacNee13MRC Centre for Inflammation Research, The Queen's Medical Research Institute, University of Edinburgh, Edinburgh, United KingdomStephan Rennard14Department of Pulmonary and Critical Care Medicine, University of Nebraska Medical Center, Omaha,Julie Yates4GlaxoSmithKline, Research Triangle Park, North Carolina,Emiel Wouters1Department of Research & Education, CIRO+, Centre of Expertise for Chronic Organ Failure, Horn, Netherlands15Department of Respiratory Medicine, Maastricht University Medical Centre+, Maastricht, NetherlandsMartijn Spruit1Department of Research & Education, CIRO+, Centre of Expertise for Chronic Organ Failure, Horn, Netherlands
- LATE-BREAKING ABSTRACT: Study to understand mortality and morbidIty in COPD (SUMMIT)By Jorgen Vestbo, Julie Anderson, Robert D. Brook, Peter Calverley, Bart Celli, Courtney Crim, Fernando Martinez, Julie Yates and David NewbyJorgen Vestbo1Centre for Respiratory Medicine and Allergy, The University of Manchester, Manchester, United KingdomJulie Anderson2Respiratory Statistics, GlaxoSmithKline, Uxbridge, Middlesex, United StatesRobert D. Brook3Division of Cardiovascular Medicine, Internal Medicine, University of Michigan, Ann Arbor, MI United StatesPeter Calverley4Respiratory Research Group, University Hospital Aintree, Liverpool, United KingdomBart Celli5Pulmonary and Critical Care Division, Brigham and Women's Hospital, Boston, MA United StatesCourtney Crim6Respiratory Research and Development, GlaxoSmithKline, Research Triangle Park, NC United StatesFernando Martinez7Division of Pulmonary and Critical Care Medicine, New York Presbyterian Hospital/Weill Cornell Medical Center, New York, NY United StatesJulie Yates6Respiratory Research and Development, GlaxoSmithKline, Research Triangle Park, NC United StatesDavid Newby8United States and British Heart Foundation Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, United Kingdom
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.